Engagement history

Selected anonymized engagements.

Client identities are confidential by default. We list anonymized engagement summaries below. Direct references can be arranged on request, with the GP’s consent, once an engagement scope is under discussion.

Buyout · ASC 820 · Quarterly · 2018–present

Mid-market buyout fund — Fund III & Fund IV quarterly mandate

Independent fair value measurements for 18 control positions across industrials, healthcare services, and tech-enabled services. OPM-based allocation across preferred and common; market multiples cross-check from a curated public-comparable set; entry-transaction calibration that decays on a defensible schedule. Direct interface with audit-firm valuation specialist; full PCAOB AS 2501 workpaper trail.

$1.2B AUM · 18 portfolios · 32 quarter-ends delivered · 100% audit-clean

[GP NAME REDACTED — REFERENCES ON REQUEST]

Secondary · GP-Led · Continuation Fund · 2024

Software-vertical continuation fund — single-asset secondary

Independent valuation supporting an LP-friendly tender at NAV crystallization. Two scenarios modeled: held-rule market case and downside calibration. OPM waterfall across four classes of preferred plus common. LP advisory committee read-out delivered with Q&A support. Negotiated fairness perspective arrived at independently of the GP and the secondary buyer.

$310M deal size · 4 share classes modeled · LP advisory committee read-out delivered

[SPONSOR REDACTED — REFERENCES ON REQUEST]

Credit · Mezzanine · Quarterly · 2022–present

Private credit fund — mezzanine portfolio quarterly marks

Yield-spread analysis and discounted cash flow valuation for 24 mezzanine positions, including PIK-toggle and ratchet provisions. Cross-check against LSTA leveraged loan index spreads for structurally comparable risk strata. Direct interface with the audit team’s valuation specialist; full PCAOB AS 2501 workpaper trail.

$680M committed capital · 24 positions · 12 consecutive quarters delivered

[FUND NAME REDACTED — REFERENCES ON REQUEST]

Growth Equity · 409A · Refresh cadence · 2021–present

Healthcare-tech growth equity — portfolio-wide 409A program

Quarterly 409A refresh for nine portfolio companies under common-stock-issuing programs. OPM and PWERM hybrid allocation across preferred stacks; backsolve to most recent priced round; calibration to public comparables and acquired-company transaction multiples on a rolling basis. Coordinated with each portfolio company’s CFO and outside counsel for board approval cycles.

9 portfolios · 36 quarter-end refreshes · zero IRS challenge

[GP NAME REDACTED — REFERENCES ON REQUEST]

PPA · ASC 805 · Single-event · 2025

Industrials add-on acquisition — purchase price allocation

Fair value of acquired tangible and intangible assets following an LBO add-on. Identified intangibles included customer relationships, trade name, developed technology, and a non-compete; contingent consideration was modeled with a Monte Carlo overlay. Audit firm signed off on the workpaper file with no follow-up requests.

$185M deal · 4 intangible asset classes identified · audit-clean at first review

[SPONSOR REDACTED — REFERENCES ON REQUEST]

Engagements above are anonymized; redacted placeholders will be replaced with named references where the GP has consented. Numbers shown are placeholders for the demo build and need to be confirmed against firm records before publication.